Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Preoperative Dialysis Dose and Postoperative Outcomes in Patients Receiving Maintenance Hemodialysis.

Preoperative Dialysis Dose and Postoperative Outcomes in Patients Receiving Maintenance Hemodialysis. Kidney360 Fielding-Singh, V., Vanneman, M. W., Morris, A. M., Winkelmayer, W. C., Sun, L. Y., Roshanov, P. S., Montez-Rath, M., Chertow, G. M., Lin, E. 2025

Abstract

Little is known about preoperative hemodialysis dosing for patients with end-stage kidney disease. We assessed whether changes in preoperative hemodialysis dose (compared to and controlling for baseline dose) are associated with postoperative mortality in patients receiving maintenance hemodialysis.We identified fee-for-service Medicare beneficiaries receiving hemodialysis for end-stage kidney disease who underwent surgical procedures between January 1, 2011, and November 30, 2020. Follow-up ended December 31, 2020. The primary exposure was preoperative change in Kt/Vurea, defined as the difference between the Kt/Vurea in the hemodialysis session proximal to the procedure and the mean Kt/Vurea for the preceding 180 days. The primary outcome was postoperative 30-day mortality. The relation between preoperative change in Kt/Vurea and the primary outcome was modeled using a Cox proportional hazards regression model, adjusted for mean and standard deviation of Kt/Vurea in the 180 days preceding the procedure, and for other covariates.Among 151,240 procedures (median age, 65 years [25%-75% range, 56-73], 63,437 (41.9%) in women), 31,825 (21.0%) had a preoperative change in Kt/Vurea of <-0.10, 43,790 (29.0%) had a preoperative change of -0.10 to < 0, 45,058 (29.8%) had a preoperative change of 0 to <+0.10, and 30,567 (20.2%) had a preoperative change of =+0.10. The median Kt/Vurea for the 180 days prior to the procedure was 1.58 (25th-75th percentiles, 1.45-1.74). In adjusted analysis, compared to patients with a preoperative change in Kt/Vurea of 0 to <+0.10, 30-day mortality was 1.50 (95% CI, 1.32, 1.70) times higher with a preoperative Kt/Vurea change of =-0.10 and 1.16 (95% CI, 1.02, 1.31) times higher with a preoperative Kt/Vurea change of -0.10 to < 0. Increases in preoperative Kt/Vurea that were greater than 0.10 were not significantly associated with 30-day mortality.Among Medicare beneficiaries receiving maintenance hemodialysis, preoperative decreases in Kt/Vurea (compared to and controlling for mean Kt/Vurea) were significantly associated with postoperative mortality.

View details for DOI 10.34067/KID.0000000874

View details for PubMedID 40504620